Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 189.93

+0.5%

Jan 2 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Wallace Rivers who wrote (29473)	11/24/1999 5:14:00 PM
From: Henry Niman	of 32384

Here is the abstract for the discovery of 9-cis retinoic acid (Panretin): Cell 1992 Jan 24;68(2):397-406 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C Ligand Pharmaceuticals, Inc., San Diego, California 92121. All-trans retinoic acid (RA) has previously been shown to modulate the transcriptional properties of the retinoic acid receptor(RAR) and retinoid X receptor (RXR). The inability of all-trans RA to bind to RXR suggests that it may be metabolized to a moreactive high affinity ligand. We report here an experimental approach that has identified 9-cis RA as an RXR ligand. It is up to40-fold more potent than all-trans RA in transfection assays and binds with high affinity. The production of 9-cis RA in cultured cells and the identification of this molecule in liver and kidney demonstrates the existence of this molecule in living organisms. The discovery of this novel hormone points to the key role retinoid metabolism may have in generating new signaling pathways. PMID: 1310260, UI: 92127596

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next